The Role of Gender in Cost-Related Medication Nonadherence Among Patients with Diabetes

References

1. 1.↵
   International Diabetes Federation. IDF Diabetes Atlas - 8^th Edition. Available from: http://www.diabetesatlas.org/. Accessed July 20, 2016.
2. 2.↵
   World Health Organization. 10 Facts About Diabetes. 2016. Available from: http://www.who.int/features/factfiles/diabetes/en/. Accessed July 24, 2016.
3. 3.↵
   Centers for Disease Control and Prevention. National Diabetes Statistics Report. 2017; Available from https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed July 28, 2018.
4. 4.↵
   1. Zhuo X,
   2. Zhang P,
   3. Barker L,
   4. et al

   . The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care 2014;37:2557–64.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   American Diabetes Association. Tight Diabetes Control. Available from: http://www.diabetes.org/living-with-diabetes/treatment-and-care/bloodglucose-control/tight-diabetes-control.html?referrer=https://www.google.com/http://www.diabetes.org/living-with-diabetes/treatment-andcare/blood-glucose-control/tight-diabetes-control.html?referrer=https://www.google.com/. Accessed August 02, 2016.
6. 6.↵
   1. Bailey CJ,
   2. Kodack M

   . Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract 2011;65:314–22.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Cramer JA

   . A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218–24.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Sokol MC,
   2. McGuigan KA,
   3. Verbrugge RR,
   4. et al

   . Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521–30.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Cramer JA,
   2. Roy A,
   3. Burrell A,
   4. et al

   . Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44–7.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Hansen RA,
    2. Kim MM,
    3. Song L,
    4. et al

    . Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009;43:413–22.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. DeFronzo RA

    . Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281–303.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Breitscheidel L,
    2. Stamenitis S,
    3. Dippel FW,
    4. et al

    . Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper. J Med Econ 2010;13:8–15.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. García-Pérez LE,
    2. Álvarez M,
    3. Dilla T,
    4. et al

    . Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013;4:175–94.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Ho PM,
    2. Rumsfeld JS,
    3. Masoudi FA,
    4. et al

    . Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836–41.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Lee WC,
    2. Balu S,
    3. Cobden D,
    4. et al

    . Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface 2006;19:31–41.

    OpenUrlPubMed
16. 16.↵
    1. Salas M,
    2. Hughes D,
    3. Zuluaga A,
    4. Vardeva K,
    5. Lebmeier M

    . Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health 2009;12:915–22.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Balkrishnan R,
    2. Rajagopalan R,
    3. Camacho FT,
    4. Huston SA,
    5. Murray FT,
    6. Anderson RT

    . Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25:2958–71.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Odegard PS,
    2. Gray SL

    . Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Edu 2008;34:692–7.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Tarn DM,
    2. Heritage J,
    3. Paterniti DA,
    4. et al

    . Physician communication when prescribing new medications. Arch Intern Med 2006;166:1855–62.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Zivin K,
    2. Ratliff S,
    3. Heisler MM,
    4. et al

    . Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health 2010;13:338–45.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Bengle R,
    2. Sinnett S,
    3. Johnson T,
    4. et al

    . Food insecurity is associated with cost-related medication non-adherence in community-dwelling, low-income older adults in Georgia. J Nutr Elder 2010;29:170–91.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Kurlander JE,
    2. Kerr EA,
    3. Krein S,
    4. et al

    . Cost-related nonadherence to medications among patients with diabetes and chronic pain factors beyond finances. Diabetes Care 2009;32:2143–8.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Piette JD,
    2. Rosland AM,
    3. Silveira MJ,
    4. et al

    . Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse. Patient Prefer Adherence 2011;5:187–94.

    OpenUrlPubMed
24. 24.↵
    1. Jackson CA,
    2. Clatworthy J,
    3. Robinson A,
    4. et al

    . Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010;105:525–39.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Piette JD,
    2. Heisler M,
    3. Wagner TH

    . Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care 2004;27:384–91.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Puskas CM,
    2. Forrest JI,
    3. Parashar S,
    4. et al

    . Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep 2011;8:277–87.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Lewey J,
    2. Shrank WH,
    3. Bowry AD,
    4. et al

    . Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J 2013;165:665–78.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Rolnick SJ,
    2. Pawloski PA,
    3. Hedblom BD,
    4. et al

    . Patient characteristics associated with medication adherence. Clin Med Res 2013;11:54–65.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Kennedy J,
    2. Morgan S

    . Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries. Clin Ther 2009;31:213–9.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Soumerai SB,
    2. Pierre-Jacques M,
    3. Zhang F,
    4. et al

    . Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med 2006;166:1829–35.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    National Health Interview Survey. Available from: http://www.cdc.gov/nchs/nhis/. Accessed July 21, 2016.
32. 32.↵
    Centers for Disease Control and Prevention, National Health Interview Survey. Available from: http://www.cdc.gov/nchs/nhis/index.htm. Accessed August 2, 2018.
33. 33.↵
    1. Aday LA,
    2. Andersen RM

    . Equity of access to medical care: a conceptual and empirical overview. Med Care. 1981;19:4–27.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Andersen R,
    2. Newman JF

    . Societal and individual determinants of medical care utilization in the United States. Millbank Q 2005;83.
35. 35.↵
    1. Lee M,
    2. Khan MM

    . Gender differences in cost-related medication non-adherence among cancer survivors. J Cancer Surviv 2016;10:384–93.

    OpenUrl
36. 36.↵
    1. McCollum M,
    2. Hansen LB,
    3. Lu L,
    4. et al

    . Gender differences in diabetes mellitus and effects on self-care activity. Gend Med 2005;2:246–54.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Williams J,
    2. Steers WN,
    3. Ettner SL,
    4. et al

    . Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Med Care 2013;51:193.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Levine DA,
    2. Morgenstern LB,
    3. Langa KM,
    4. et al

    . Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol 2013;73:180–8.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Morello CM,
    2. Hirsch JD

    . Strategies for addressing the cost of nonadherence in diabetes. Am J Manag Care 2017;23:S247–52.

    OpenUrl
40. 40.↵
    1. Weeks G,
    2. George J,
    3. Maclure K,
    4. Stewart D

    . Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev 2016 Jul 22(7).
41. 41.↵
    1. Kymes SM,
    2. Pierce RL,
    3. Girdish C,
    4. Matlin OS,
    5. Brennan T,
    6. Shrank WH

    . Association among change in medical costs, level of comorbidity, and change in adherence behavior. Am J Manag Care 2016;22:e295–301.

    OpenUrl
42. 42.↵
    1. Patel MR,
    2. Piette JD,
    3. Resnicow K,
    4. et al

    . Social determinants of health, cost-related nonadherence, and cost-reducing behaviors among adults with diabetes: findings from the National Health Interview Survey. Med Care 2016;54:796–803.

    OpenUrlCrossRefPubMed
43. 43.↵
    1. Blumberg DM,
    2. Prager AJ,
    3. Liebmann JM,
    4. Cioffi GA,
    5. De Moraes CG

    . Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of Medicare Part D. JAMA Ophthalmol 2015;133:985–96.

    OpenUrl
44. 44.↵
    1. Jianakoplos NA,
    2. Bernasek A

    . Are women more risk averse? Econ Inq 1998;36:620–30.

    OpenUrlCrossRefWeb of Science
45. 45.↵
    1. Powell M,
    2. Ansic D

    . Gender differences in risk behaviour in financial decision-making: an experimental analysis. J Econ Psychol 1997;18:605–28.

    OpenUrlCrossRef